UK regulator reports rise in drug approvals and steps toward AI oversight in healthcare
read at raps ↗RegulatoryNeutral
The UK Medicines and Healthcare products Regulatory Agency (MHRA) released its 2025-2026 annual report to Parliament.
The agency highlighted that it approved more new medicines this year than in the previous year, marking an uptick in its approval activity.
It also reported the removal of a record number of illegal drugs from circulation during the period.
Additionally, the MHRA outlined plans to advance the regulation of artificial intelligence applications in healthcare.
source
This writeup was produced by pharmadog from original reporting by raps.
Original headline: “Recon: Lilly to buy psychedelic developer AtaiBeckley for up to $3.8B; FDA approves Merck’s novel cholesterol drug”
read at raps ↗68 words · retrieved Jul 20
comments(0)
5-min edit window · permanent after that